Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Hypercholesterolemia;Dyslipidemias, Date of authorisation: 09/12/2020, Revision: 5, Status: Authorised
TO: